Onconova Therapeutics Inc (ONTX)

2.08
0.02 0.95
NASDAQ : Health Care
Prev Close 2.10
Open 2.12
Day Low/High 2.07 / 2.12
52 Wk Low/High 3.30 / 40.00
Volume 85.60K
Avg Volume 145.90K
Exchange NASDAQ
Shares Outstanding 6.77M
Market Cap 14.29M
EPS -4.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Onconova Therapeutics, Inc. To Provide Corporate Update And Full Year 2016 Financial Results

Onconova Therapeutics, Inc. To Provide Corporate Update And Full Year 2016 Financial Results

Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Monday, March 27, 2017

5 Stocks Under $10 That Could Rocket Higher Soon

5 Stocks Under $10 That Could Rocket Higher Soon

Keep an eye on these cheap stocks.

These 5 Stocks Under $10 Could Get Hot Soon

These 5 Stocks Under $10 Could Get Hot Soon

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Onconova And Cellworks Announce Presentation Of Rigosertib Predictive Signature For Clinical Response In Myelodysplastic Syndromes (MDS) At 2016 ASH Annual Meeting

Onconova And Cellworks Announce Presentation Of Rigosertib Predictive Signature For Clinical Response In Myelodysplastic Syndromes (MDS) At 2016 ASH Annual Meeting

Computational Subgroup Analysis of Phase 3 ONTIME Trial Provides Insights into Clinical Response to Rigosertib in Higher-risk MDS

Onconova Announces Successful End-of-Phase 2 Meeting With FDA For Oral Rigosertib And Azacitidine Combination

Onconova Announces Successful End-of-Phase 2 Meeting With FDA For Oral Rigosertib And Azacitidine Combination

Pivotal Randomized Trial in 1st-line MDS Patients will Assess Overall Response Rate as Approval Endpoint

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering breakout trades.

7 Stocks Under $10 Making Big Up Moves

7 Stocks Under $10 Making Big Up Moves

Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.

Onconova Announces Enrollment Of First Patient In Japan By SymBio

Onconova Announces Enrollment Of First Patient In Japan By SymBio

Global Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes Now Active in More than 90 Sites